Cargando…

COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021

BACKGROUND: : Despite investigations on the effect of disease modifying therapies (DMTs) used in multiple sclerosis (MS) on coronavirus disease 2019 (COVID-19); there are still controversies. OBJECTIVE: : We designed this study to evaluate the epidemiological features of covid-19 in a large sample o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naghavi, Saba, Kavosh, Aryan, Adibi, Iman, Shaygannejad, Vahid, Arabi, Sina, Rahimi, Maryam, Mazaheri, Shahbanoo, Ashtari, Fereshteh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519664/ https://www.ncbi.nlm.nih.gov/pubmed/35158427 http://dx.doi.org/10.1016/j.msard.2021.103335

Ejemplares similares

Paraparesis due to aortic thromboembolism as a rare complication of COVID-19 infection
por: Motahharynia, Ali, et al.
Publicado: (2021)

Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19
por: Motahharynia, Ali, et al.
Publicado: (2022)

Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
por: Motahharynia, Ali, et al.
Publicado: (2022)

Presentation of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) in the Acute Phase of COVID-19 Infection
por: Jalilian, Zeynab, et al.
Publicado: (2023)

A mechanistic insight into sources of error of visual working memory in multiple sclerosis
por: Motahharynia, Ali, et al.
Publicado: (2023)

Patterns of attention deficit in relapsing and progressive phenotypes of multiple sclerosis
por: Tabibian, Farinaz, et al.
Publicado: (2023)

Psychological well-being in people with multiple sclerosis in an Iranian population
por: Dehnavi, Sedigheh Rezaei, et al.
Publicado: (2015)

Does early-onset multiple sclerosis differ from adult-onset form in Iranian people
por: Ashtari, Fereshteh, et al.
Publicado: (2010)

Quantitative Magnetic Resonance Imaging Analysis of Early Markers of Upper Cervical Cord Atrophy in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Adibi, Iman, et al.
Publicado: (2021)

Study of Type A and B Behavior Patterns in Patients with Multiple Sclerosis in an Iranian Population
por: Shaygannejad, Vahid, et al.
Publicado: (2013)

Preliminary Study Related the Incidence of Methylprednisolone Pulse Therapy in Patients Visited Multiple Sclerosis Clinic Located at the Isfahan Kashani Hospital
por: Tolou-Ghamari, Zahra, et al.
Publicado: (2013)

Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran
por: Shamsian, Fereshteh, et al.
Publicado: (2019)

Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial
por: Shaygannejad, Vahid, et al.
Publicado: (2012)

Fear and anxiety in patients with multiple sclerosis during COVID-19 pandemic; report of an Iranian population
por: Ramezani, Neda, et al.
Publicado: (2021)

The relation between Vitamin D status with fatigue and depressive symptoms of multiple sclerosis
por: Ashtari, Fereshteh, et al.
Publicado: (2013)

Preliminary study on patients located at the Kashani/Isfahan Hospital with multiple sclerosis between the years 2011 and 2013
por: Tolou-Ghamari, Zahra, et al.
Publicado: (2015)

MS Care in Novel Coronavirus 19 Pandemic
por: Ramezani, Neda, et al.
Publicado: (2020)

Managing anxiety among multiple sclerosis patients during COVID-19 pandemic
por: Adibi, Iman, et al.
Publicado: (2021)

Rivaroxaban in Recurrent Ischemic Stroke Due to Protein S Deficiency: A Case Report
por: Naghavi, Saba, et al.
Publicado: (2021)

The pathologic and diagnostic in magnetic resonance imaging of brain and cervical spine of patients with neuromyelitis optica spectrum disorder
por: Mehdipour-Dastjerdi, Roshanak, et al.
Publicado: (2018)

Seizure in Iranian patients with multiple sclerosis
por: Zare, Mohammad, et al.
Publicado: (2013)

Seizure characteristics in multiple sclerosis patients
por: Shaygannejad, Vahid, et al.
Publicado: (2013)

Preliminary analysis of month of birth in Iranian/Isfahan patients with multiple sclerosis
por: Tolou-Ghamari, Zahra, et al.
Publicado: (2015)

Color blindness among multiple sclerosis patients in Isfahan
por: Shaygannejad, Vahid, et al.
Publicado: (2012)

COVID and Cardiovascular Disease: What We Know in 2021
por: Chilazi, Michael, et al.
Publicado: (2021)

Post-discharge health assessment in survivors of coronavirus disease: a time-point analysis of a prospective cohort study
por: Sami, Ramin, et al.
Publicado: (2023)

Editorial: “We Know What We Are, but Know Not What We May Be”: Metacognition and Self-Awareness in the Aging Brain
por: Orfei, Maria Donata, et al.
Publicado: (2021)

Familial Mediterranean Fever and Transverse Myelitis: A Causal Relation?
por: Motahharynia, Ali, et al.
Publicado: (2023)

Demographic features and clinical characteristics of patients with Parkinson’s disease in Isfahan, Iran
por: Salari, Mehri, et al.
Publicado: (2018)

The environmental risk factors in multiple sclerosis susceptibility: A case-control study
por: Shaygannejad, Vahid, et al.
Publicado: (2016)

What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
por: Yoo, Jin-Hong
Publicado: (2021)

Ivermectin in COVID-19: What do we know?
por: Pandey, Sanjay, et al.
Publicado: (2020)

Restless Legs Syndrome in Iranian Multiple Sclerosis Patients: A Case-Control Study
por: Shaygannejad, Vahid, et al.
Publicado: (2013)

Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study
por: Ashtari, Fereshte, et al.
Publicado: (2017)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Statin Intolerance—We Know Everything, We Know Nothing
por: Banach, Maciej
Publicado: (2022)

Big Tau: What We Know, and We Need to Know
por: Fischer, Itzhak
Publicado: (2023)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hp2b2h1ifl96lcf995hha0hvbl